These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 13364127)

  • 21. Association of nucleic acids and cellular membranes induced by a carcinogen, -propiolactone.
    Kubinski H; Andersen PR; Kellicutt LM
    Chem Biol Interact; 1972 Sep; 5(4):279-83. PubMed ID: 5075759
    [No Abstract]   [Full Text] [Related]  

  • 22. The sterilization of human arterial homografts with beta-propiolactone; experimental and clinical observations.
    SZILAGYI DE; OVERHULSE PR; SHONNARD CP; LOGRIPPO GA
    Surg Forum; 1955; 5():244-52. PubMed ID: 13247029
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of beta-propiolactone for the preparation of virus vaccines. II. Antigenicity.
    POLLEY JR; GUERIN MM
    Can J Microbiol; 1957 Oct; 3(6):871-7. PubMed ID: 13472512
    [No Abstract]   [Full Text] [Related]  

  • 24. [Reaction of p-nitro-phenyl-beta-propiolactone with amines].
    DORNOW A; SCHUMACHER E
    Arch Pharm Ber Dtsch Pharm Ges; 1953; 286(4):205-11. PubMed ID: 13081113
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of beta-propiolactone on the metabolism of Blastomyces dermatitidis.
    GALE GR
    J Bacteriol; 1953 May; 65(5):505-8. PubMed ID: 13069412
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of beta-propiolactone on metabolism of pseudomonas aeruginosa and growth of certain fungi.
    BERNHEIM F; GALE GR
    Proc Soc Exp Biol Med; 1952 May; 80(1):162-4. PubMed ID: 14930106
    [No Abstract]   [Full Text] [Related]  

  • 27. Circadian variation in the susceptibility of mouse epidermis to chemical carcinogens.
    Iversen OH; Kauffman SL
    Int J Chronobiol; 1981; 8(1):49-62. PubMed ID: 7341497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of an artery-graft bank; with special reference to sterilisation by beta-propiolactone.
    BARSON GJ; CRAWFORD N; RAINS AJ; SHARPE SH; SHREWSBURY JF
    Lancet; 1956 Oct; 271(6947):830-2. PubMed ID: 13368532
    [No Abstract]   [Full Text] [Related]  

  • 29. DNA-protein complexes produced by a carcinogen, beta-propiolactone.
    Nietert WC; Kellicutt LM; Kubinski H
    Cancer Res; 1974 Apr; 34(4):859-64. PubMed ID: 4814998
    [No Abstract]   [Full Text] [Related]  

  • 30. The early stimulation of phospholipid metabolism by 12-0-tetradecanoyl-phorbol-13-acetate and its specificity for tumor promotion.
    Rohrschneider LR; Boutwell RK
    Cancer Res; 1973 Aug; 33(8):1945-52. PubMed ID: 4720803
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of beta-propiolactone-induced mutagenesis and neoplasia by sodium thiosulfate.
    Wattenberg LW; Hochalter JB; Galbraith AR
    Cancer Res; 1987 Aug; 47(16):4351-4. PubMed ID: 3607767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further studies on the carcinogenic and growth-inhibitory activity of lactones and related substances.
    DICKENS F; JONES HE
    Br J Cancer; 1963 Mar; 17(1):100-8. PubMed ID: 14027702
    [No Abstract]   [Full Text] [Related]  

  • 33. ß-Propiolactone.
    National Toxicology Program
    Rep Carcinog; 2004; 11():III225-6. PubMed ID: 21105255
    [No Abstract]   [Full Text] [Related]  

  • 34. Oncogene activation in experimental carcinogenesis: the role of carcinogen and tissue specificity.
    Garte SJ; Hochwalt AE
    Environ Health Perspect; 1989 May; 81():29-31. PubMed ID: 2759063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The binding of beta-propiolactone to mouse skin DNA in vivo; its correlation with tumor-initiating activity.
    Colburn NH; Boutwell RK
    Cancer Res; 1966 Aug; 26(8):1701-6. PubMed ID: 5923168
    [No Abstract]   [Full Text] [Related]  

  • 36. CARCINOGENICITY OF OXY COMPOUNDS.
    ORRIS L; VANDUUREN L; NELSON N
    Acta Unio Int Contra Cancrum; 1963; 19():644-7. PubMed ID: 14050626
    [No Abstract]   [Full Text] [Related]  

  • 37. The in vivo binding of beta-propiolactone to mouse skin DNA, RNA, and protein.
    Colburn NH; Boutwell RK
    Cancer Res; 1968 Apr; 28(4):642-52. PubMed ID: 5649055
    [No Abstract]   [Full Text] [Related]  

  • 38. The effects of propiolactone on rat fibrocytes cultivated in vitro.
    Powell AK
    Br J Cancer; 1966 Jun; 20(2):402-13. PubMed ID: 5944281
    [No Abstract]   [Full Text] [Related]  

  • 39. beta-Propiolactone.
    National Toxicology Program
    Rep Carcinog; 2002; 10():207-8. PubMed ID: 15334719
    [No Abstract]   [Full Text] [Related]  

  • 40. Further tests on the carcinogenicity of sorbic acid in the rat.
    Dickens F; Jones HE; Waynforth HB
    Br J Cancer; 1968 Dec; 22(4):762-8. PubMed ID: 5750785
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.